Can a blood test tell patients if their cancer is coming back? Researchers are on it
Researchers at Toronto's Princess Margaret Cancer Centre are launching a 7,000-patient trial called SHERLOCK to test if liquid biopsies can detect microscopic cancer DNA after treatment. The study aims to determine if these blood tests can predict cancer recurrence and guide personalized follow-up care.
Why it matters
If successful, this method could revolutionize cancer monitoring by allowing for earlier intervention or preventing unnecessary, toxic treatments for patients who are already cancer-free.
TORONTO - Researchers at Princess Margaret Cancer Centre in Toronto are working on a large trial to determine if a blood test can detect tiny amounts of cancer remaining after patients have been treated.
The article provides a straightforward, factual report on a medical study without emotive language or political framing.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in